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1 18 
ABSTRACT 19 
The insect GABA receptor, RDL, is the target of several classes of pesticides. The peptide sequences of 20 
RDL are generally highly conserved between diverse insects. However, RNA A-to-I editing can 21 
effectively alter amino acid residues of RDL in a species specific manner, which can affect the potency of 22 
GABA and possibly insecticides. We report here that RNA A-to-I editing alters the gene products of Rdl 23 
in three mosquito disease vectors, recoding five amino acid residues in RDL of Aedes aegypti and six 24 
residues in RDLs of Anopheles gambiae and Culex pipiens, which is the highest extent of editing in RDL 25 
observed to date. Analysis of An. gambiae Rdl cDNA sequences identified 24 editing isoforms 26 
demonstrating a considerable increase in gene product diversity. RNA editing influenced the potency of 27 
the neurotransmitter, GABA, on An. gambiae RDL editing isoforms expressed in Xenopus laevis oocytes, 28 
as demonstrated by EC50s ranging from 5 ± 1 to 246 ± 41 M. Fipronil showed similar potency on 29 
different editing isoforms, with IC50s ranging from 0.18 ± 0.08 to 0.43 ± 0.09 M. In contrast, editing of 30 
An. gambiae RDL affected the activating, potentiating and inhibiting actions of ivermectin. For example, 31 
ivermectin potentiated currents induced by GABA at the EC20 concentration in the unedited isoform but 32 
not in the fully edited variant. Editing of a residue in the first transmembrane domain or the cys-loop 33 
influenced this potentiation, highlighting residues involved in the allosteric mechanisms of cys-loop 34 
ligand-gated ion channels. Understanding the interactions of ivermectin with molecular targets may have 35 
relevance to mosquito control in areas where people are administered with ivermectin to treat parasitic 36 
diseases. 37 
 38 
Keywords: electrophysiology, fipronil, GABA receptor, ivermectin, mosquito, RNA editing 39 
 40 
1. Introduction 41 
The insect -aminobutyric acid (GABA) receptor RDL (resistant to dieldrin) plays central neuronal roles 42 
in various processes, including regulation of sleep (Liu et al., 2014), aggression (Yuan et al., 2014) and 43 
olfactory learning (Liu et al., 2009). It is a member of the cys-loop ligand-gated ion channel superfamily, 44 
which also includes nicotinic acetylcholine receptors (nAChRs) and glutamate-gated chloride channels 45 
(GluCls). RDL therefore contains an N-terminal extracellular domain where GABA binding occurs, the 46 
characteristic cys-loop motif consisting of two disulphide bond-forming cysteines separated by 13 amino 47 
acids, and four transmembrane (TM) domains (Nys et al., 2013). 48 
 RDL is also of interest as it is the target of highly effective insecticides (Buckingham et al., 49 
2017). Studies on the model organism Drosophila melanogaster identified a mutation in genomic DNA 50 
resulting in an alanine to serine substitution located in TM2, which underlies resistance to several 51 
insecticides including dieldrin, picrotoxin and fipronil (Ffrench-Constant et al., 1993; Hosie et al., 1995). 52 
                                                          
Abbreviations: ADAR – adenosine deaminase that acts on RNA; GABA – -aminobutyric acid; nAChR – nicotinic 
acetylcholine receptor; RDL – resistant to dieldrin, an insect GABA receptor; TM – transmembrane domain 
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This alanine to serine mutation, also found as alanine to glycine or to asparagine, has since been 53 
associated with insecticide resistance in varying species, ranging from crop pests [e.g. the planthopper 54 
Laodelphax striatellus (Nakao, 2017)], pests afflicting livestock [the horn fly Haematobia irritans 55 
(Domingues et al., 2013)] or domesticated animals [the cat flea Ctenocephalides felis (Bass et al., 2004)], 56 
and disease vectors [the malaria mosquito Anopheles gambiae (Du et al., 2005; Taylor-Wells et al., 57 
2015)]. Despite the emergence of insecticide resistance, RDL is still a potential target for insect control 58 
since novel compounds have been developed that are unaffected by the TM2 resistance mutation (Casida 59 
and Durkin, 2015). 60 
 RDL peptide sequences, as translated from genomic DNA, are highly conserved between diverse 61 
insect species, as shown by RDL sharing 69-90%  identity (considering the whole subunit) in the honey 62 
bee (Apis mellifera), D. melanogaster, the parasitoid wasp (Nasonia vitripennis) and the red flour beetle 63 
(Tribolium castaneum) (Jones et al., 2010; Jones and Sattelle, 2006; Jones and Sattelle, 2007; Taylor-64 
Wells et al., 2017). However, the diversity of RDL can be increased by RNA A-to-I editing. During this 65 
process, adenosine deaminases that act on RNA (ADARs) remove an amine group from certain adenosine 66 
residues in pre-mRNA to generate the rare nucleoside, inosine (Deffit and Hundley, 2016). Because 67 
inosine is interpreted by cellular machineries as guanosine, A-to-I editing produces transcripts with a 68 
nucleotide composition distinct from the corresponding genomic DNA. For example, RNA editing 69 
effectively alters four amino acid residues in the D. melanogaster RDL (Hoopengardner et al., 2003). In 70 
contrast, RDL from A. mellifera, T. castaneum and N. vitripennis were found not to undergo RNA A-to-I 71 
editing (Jones et al., 2010; Jones and Sattelle, 2006; Jones and Sattelle, 2007) whereas RDL 1 from the 72 
silk worm, Bombyx mori, has two potential RNA editing sites that differ to those found in Drosophila (Yu 73 
et al., 2010). Thus, RNA A-to-I editing generates RDL isoforms in a species specific manner.  74 
RNA A-to-I can have an impact on receptor function. For example, two-electrode voltage-clamp 75 
electrophysiology applied to D. melanogaster RDL isoforms expressed in Xenopus laevis oocytes showed 76 
that RNA editing modulates agonist potency and thus may fine-tune the sensitivity of the GABA receptor 77 
to its neurotransmitter (Jones et al., 2009). Furthermore, RNA A-to-I of RDL may affect the potency of 78 
insecticides as indicated by the finding that Drosophila RDL with an R122G editing variant was found to 79 
be less sensitive to fipronil (Es-Salah et al., 2008). It is therefore prudent to determine whether RDL 80 
undergoes RNA editing in pests as an instructive step in assessing whether there may be a species specific 81 
effect on insecticide potency.  82 
Recently, it was observed that RDL from An. gambiae has at least two potential A-to-I RNA 83 
editing sites, I176V and N183G (Taylor-Wells et al., 2015), neither of which were found in Drosophila 84 
RDL. To understand further the molecular complexity of the GABA receptor in major disease vectors, we 85 
report here the identification of RNA A-to-I editing sites in RDL from not only An. gambiae, but also 86 
from Aedes aegypti, and Culex pipiens, mosquitoes that spread dengue fever and West Nile virus, 87 
respectively (World Health Organization a). In addition, we used two-electrode voltage-clamp 88 
electrophysiology applied to heterologously expressed mosquito RDL to measure the impact of RNA 89 
editing on the potency of GABA, fipronil and ivermectin. 90 
 91 
2. Materials and methods 92 
2.1. Materials 93 
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All chemicals, including the insecticides fipronil and ivermectin, were purchased from Sigma 94 
Aldrich (Dorset, UK), unless otherwise stated.  95 
 96 
2.2. Identification of RNA editing sites in mosquito Rdl 97 
Wild type adult mixed gender An. gambiae PEST strain mosquitoes, Ae. aegypti and Cx. pipiens 98 
were obtained from the National Institute of Health (MA, USA). Total RNA was extracted from groups of 99 
ten mosquitoes using Trizol reagent according to the protocol supplied. First-strand cDNA was 100 
synthesized as described previously (Jones et al., 2005) using M-MLV reverse transcriptase (Thermo 101 
Fisher Scientific, Loughborough, UK). The cDNA coding sequence of Rdl from the three mosquito 102 
species were amplified using PfuTurbo DNA Polymerase (Agilent Technologies, Stockport, UK) and 103 
primers listed in the Supplemental Material (Table S1). RNA editing was identified by Sanger sequencing 104 
(Source Bioscience, Oxford, UK) of the cDNA sequences and sequence chromatograms visualised by 105 
Chromas Lite (Technelysium, Brisbane, AUS). Frequency of editing was estimated by ratiometric A/G 106 
measurement from sequence chromatograms (Jepson and Reenan, 2007). An. gambiae genomic DNA 107 
present in the extracted total RNA, which was first treated with DNase-free RNase (Roche, West Sussex, 108 
UK), was amplified using primers recognizing introns (see Supplementary Material for primer sequences) 109 
before being sequenced. 110 
 111 
2.3. Expression of RDL in X. laevis oocytes and two-electrode voltage-clamp electrophysiology 112 
The full length Rdl sequence was cloned into the pCI vector (Promega) with flanking primers 113 
containing EcoRI (TTTTTTGAATTCATGTCGCTAACTATCGAAGTTCCGC) and NotI 114 
(AAAAAAGCGGCCGCTTACTTCTCCTCGCC) (Rdl sequence underlined), and 123 clones were 115 
sequenced. Isoforms with single RNA edit sites not found in vivo were generated using the QuikChange II 116 
Site-Directed Mutagenesis kit (Agilent Technologies) using oligonucleotides listed in the Supplementary 117 
Material (Table S2). The functional effects of the different An. gambiae Rdl RNA editing isoforms were 118 
evaluated using the X. laevis expression system and two-electrode voltage-clamp electrophysiology. X. 119 
laevis were purchased from Xenopus 1, Dexter, Michigan, USA and were handled strictly adhering to the 120 
guidelines of the Scientific Procedure Act, 1986, of the United Kingdom. Stage V and VI oocytes were 121 
harvested and rinsed with Ca2+ free solution (82 mM NaCl, 2 mM KCl, 2 mM MgCl2, 5 mM HEPES, pH 122 
7.6), before defolliculating with 1 mg/ml type IA collagenase in Ca2+ free solution. Defolliculated oocytes 123 
were injected with 3.5 ng (23 nl) Rdl plasmid DNA into the nucleus of the oocyte and stored in standard 124 
Barth’s solution (supplemented with 5% horse serum, 50 g/ml neomycin and 10 g/ml 125 
penicillin/streptomycin) at 17.5oC. Oocytes 2-7 days post-injection were placed in a recording chamber 126 
and clamped at -60 mV with two 3 M KCl filled borosilicate glass electrodes (resistance 0.5 - 5 MΩ) and 127 
an Oocyte Clamp OC-725C amplifier (Warner Instruments, CT, USA). Responses were recorded on a 128 
flatbed chart recorder (Kipp & Zonen BD-11E, Delft, Netherlands). Oocytes were perfused with standard 129 
oocyte saline (SOS; 100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.6) or 130 
Ringer’s solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl2, 10 mM HEPES, pH 7.2) at a flow rate of 131 
10 ml/min. Oocytes were selected for experiments if stable after three consecutive challenges of 1 mM 132 
GABA. 133 
GABA concentration response curves were generated by challenging oocytes to increasing 134 
concentrations of GABA in Ringers solution, with 3 min between challenges. Curves were calculated by 135 
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normalizing the GABA responses to the mean of control responses induced by 1 mM GABA before and 136 
after application. 137 
Fipronil and ivermectin inhibition curves were generated by inhibiting 1 mM GABA in SOS with 138 
0.0001 – 10 µM fipronil/ivermectin, diluted initially in dimethyl sulphoxide (DMSO), then to final 139 
concentrations in SOS. Final concentrations of 0.1% DMSO did not affect electrophysiological readings. 140 
Oocytes were initially incubated with a perfusion of the insecticide in SOS for 3 min before challenging 141 
with 1 mM GABA plus insecticide, at the required concentrations. Inhibition curves were calculated by 142 
normalising the responses to the previous control response induced by 1 mM GABA. 143 
Ivermectin agonist and potentiating actions were measured by pre-incubating the oocytes with 144 
ivermectin in SOS for 3 minutes immediately followed by a combination of ivermectin and the respective 145 
EC20 GABA concentration (1 M for the unedited, 15 M for N183G, 10 M for I278V and 80 M for 146 
the completely edited isoforms) of the RDL construct for 12 seconds. This was followed by a wash step 147 
for 3 minutes and the above steps were repeated with increasing concentrations of ivermectin. 148 
 149 
2.4. Data analysis 150 
Data are represented as mean ± SEM of individual oocytes from ≥ 3 different batches of eggs. 151 
The concentration of GABA required to evoke 50% of the maximum response (EC50), the concentration 152 
of insecticide required to inhibit 50% of the maximal GABA response (IC50) and the Hill coefficient (nH) 153 
were determined by nonlinear regression using Graphpad Prism 5 (Graphpad Software, CA, USA). 154 
Statistical significance was determined by using one-way ANOVA with Dunnett’s multiple comparison 155 
post-hoc test or unpaired t-test (Graphpad). 156 
 157 
3. Results 158 
3.1. RDL transcripts of Ae. aegypti, An. gambiae and Cx. pipiens undergo RNA A-to-I editing 159 
Sequence traces of cDNA PCR products were analysed to identify potential RNA editing sites in 160 
the Rdl coding region of Ae. aegypti,  An. gambiae and  Cx. pipiens (Fig. 1). Across all three mosquito 161 
species, a total of ten putative A-to-I editing sites were observed, as indicated by a mixture of A and G 162 
peaks in the sequence chromatograms or guanosine replacing the adenosine present in the genomic DNA 163 
(such as for N183G). Not all nine editing sites were found in a single species. Instead, six sites were seen 164 
in Ae. aegypti Rdl, eight in Cx. pipiens while the most with nine sites were in An. gambiae Rdl. Mixtures 165 
of adenosine and guanosine were not observed in sequence traces of An. gambiae genomic DNA (Fig. 1) 166 
and adenosine residues were present at equivalent sites in genomic DNA sequences of Ae. aegypti and Cx. 167 
pipiens (Giraldo-Calderon et al., 2015), confirming that the nucleotide changes occur at the RNA level.  168 
RNA editing at seven of the sites results in amino acid changes (Fig. 1), five of which (R119G, I162V, 169 
I176V, N183G and M240V) occur in the N-terminal extracellular domain where agonist binding occurs 170 
(Fig. 2), the sixth (I278V) in TM1 and the seventh (N289D) in the region between TM1 and TM2. 171 
Recoding of two of the amino acid residues (I278V and N289D) was also seen in D. melanogaster RDL 172 
(Fig. 2). To determine if identification of RNA editing sites is reproducible, we analysed Rdl sequences 173 
from five RT-PCR reactions, each from a different group of An. gambiae mosquitoes. We observed mixed 174 
A and G peaks in each sequence chromatogram with the average frequencies (± standard deviation) of 175 
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editing being: R119G = 49 ± 28%; I162V = 70 ± 11%; I176V = 63 ± 33%; N183G = 96 ± 7%; I278V = 176 
56 ± 27%; N289D = 38 ± 31%. 177 
 178 
3.2. Presence of different RNA editing profiles increases the complexity of Rdl transcripts 179 
To identify RNA editing profiles present in vivo, 123 An. gambiae Rdl cDNA clones were 180 
sequenced. DNA sequencing revealed four variants (ac, ad, bc, bd) (Fig. 3) resulting from alternative 181 
splicing of exons 3 and 6 (ffrench-Constant and Rocheleau, 1993), which is highly conserved in diverse 182 
insect species (Jones et al., 2010; Jones and Sattelle, 2006; Jones and Sattelle, 2007; Yu et al., 2010). As 183 
is the case for D. melanogaster (Jones et al., 2009), the bd splice variant was the most predominant splice 184 
variant, present in 100 of the 123 clones (figure 2). This was followed by ad (19 clones), ac (3 clones) and 185 
bc (1 clone).  186 
 Across the four splice variants, a total of 24 RNA editing profiles were observed (Table 1). Of 187 
these, 22 profiles were identified in the bd splice background of which 188 
R119G+I162V+I176V+N183G+I278V was the most predominant, occurring in 28% of the clones. The 189 
I162V+N183G+I278V+N289D and unedited isoforms were not found in the bd splice background, 190 
instead being observed in ad and bc splice variants, respectively. The N183G edit (caused by an aat→ggt 191 
codon change) was the only profile found with a single edit in vivo. Another edit profile was observed, 192 
N183D+I278V, where the N183D edit was caused by an aat→gat codon change, showing that RNA A-to-193 
I editing can generate two different amino acids at the same site. 194 
 195 
3.3 RNA editing of mosquito RDL generates a spectrum of sensitivities to GABA 196 
To determine if RNA A-to-I editing of mosquito RDL modulates the potency of GABA, a total of 197 
18 isoforms in the predominant bd splice background were used for functional analysis (Table 2). Seven 198 
of these isoforms reflect editing at each individual site. Since only one single edit isoform (N183G) was 199 
found in vivo (Table 1), the remaining six isoforms were generated by site-directed mutagenesis. Ten 200 
isoforms tested have editing in at least two sites forming profiles found in vivo (Table 1), including the 201 
three most abundant isoforms (R119G+I162V+I176V+N183G+I278V, I162V+N183G+I278V and 202 
I162V+I176V+N183G+I278V), the isoform with editing at every site 203 
(R119G+I162V+I176V+N183G+I278V+N289D) and more rare isoforms (N183G+N289D and 204 
R119G+N183G). A completely unedited isoform was also used for comparison, which was generated by 205 
site-directed mutagenesis since it was not found in vivo in the bd splice background (Table 1).  206 
All 18 of the editing isoforms formed functional receptors when expressed in Xenopus oocytes, 207 
responding to GABA in a concentration-dependent manner as measured by two-electrode voltage-clamp 208 
electrophysiology (Fig. 4A). Two-electrode voltage-clamp electrophysiology also showed that RNA 209 
editing can affect the sensitivity of RDL to GABA. All editing isoforms observed in vivo increased the 210 
GABA EC50 when compared to the unedited subunit (Table 2). There was a significant difference 211 
between the GABA EC50s of five of the editing profiles and the unedited RDL isoform (Table 2). Two of 212 
these significantly different edit profiles were the most prevalent 213 
(R119G+I162V+I176V+N183G+I278V) and completely edited 214 
(R119G+I162V+I176V+N183G+I278V+N289D) isoforms. The shift in sensitivity from the unedited 215 
isoform to the completely edited isoform is demonstrated in the concentration response curves in Fig. 4B. 216 
 217 
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 3.4. RNA editing does not affect fipronil potency 218 
Functional analysis was also conducted to determine whether RNA editing affects RDL 219 
sensitivity to the antagonist fipronil. Fipronil inhibition curves were generated for the unedited isoform as 220 
well as 11 selected edit isoforms found in vivo (Fig. 5, Table 2). As indicated by IC50 values, the 221 
sensitivity of RDL to fipronil was not significantly affected by RNA editing (Fig. 5). 222 
 223 
3.5. RNA editing affects ivermectin potency 224 
Two-electrode voltage-clamp electrophysiology was used to measure the actions of ivermectin on 225 
An. gambiae RDL. We found that ivermectin acts as an antagonist on An. gambiae RDL currents induced 226 
by a GABA concentration higher than the EC50 (Fig. 6A). In addition, the ivermectin IC50 of unedited 227 
RDLbd (457 ± 118 nM) was significantly higher than the IC50 of the completely edited 228 
(R119G+I162V+I176V+N183G+I278V+N289D) isoform (50 ± 24 nM) (Table 2) (Fig. 6B), indicating 229 
that RNA editing can affect the potency of ivermectin. We also found that ivermectin alone, notably at 230 
concentrations of 0.01  and higher, elicited a sustained current in the unedited isoform whilst this 231 
irreversible agonist effect was significantly less in the fully edited variant (Fig. 7A and B). Similarly, 0.01 232 
 and 0.03  ivermectin potentiated currents induced by GABA at the EC20 in the unedited isoform 233 
but not in the fully edited variant (Fig. 7A and C). In order to determine whether RNA editing at 234 
individual sites can affect ivermectin action, we measured potentiation by ivermectin on the N183G and 235 
I278V single editing isoforms. For both isoforms, potentiation by ivermectin with GABA EC20 was 236 
abolished, similar to that of the fully edited variant (Fig. 8), indicating that editing at either site affects 237 
potency of ivermectin.    238 
 239 
4. Discussion 240 
We report here the identification of RNA A-to-I editing that can recode the genome to alter up to 241 
seven amino acid residues in the RDL GABA receptor of the mosquito species; Ae. aegypti, An. gambiae 242 
and Cx. pipiens. These findings confirm our previous suggestion that A-to-I editing generates I176V and 243 
N183G substitutions in An. gambiae RDL (Taylor-Wells et al., 2015). Two of the editing sites, I278V and 244 
N289D, are also found in Drosophila RDL (Fig. 2) (Hoopengardner et al., 2003) whilst none of these 245 
sites are shared with the two recoded amino acids in RDL1 of B. mori (Yu et al., 2010), highlighting that 246 
RNA editing generates species-specific isoforms. Editing at residue 162 of mosquito RDL recodes an 247 
isoleucine to a valine, whilst valine is already encoded for by the Drosophila genome (Fig. 2). A-to-I 248 
editing of sites which are genomically encoding guanosine in other species has also been observed for the 249 
insect 6 nicotinic acetylcholine receptor (nAChR) subunit. This lead to the suggestion that RNA editing 250 
might act as an evolutionary intermediate form between single nucleotide polymorphism sites, 251 
maintaining partial conservation at the protein and functional level, despite sequence divergence at the 252 
DNA level (Jin et al., 2007). 253 
An. gambiae RDL was chosen as a representative mosquito GABA receptor in order to further 254 
study the complexity of this insecticide target in important disease vectors. Analysis of 100 cDNAs of 255 
Drosophila RDL revealed eight isoforms with different RNA editing profiles (Jones et al., 2009). 256 
Considering that An. gambiae RDL possesses two additional amino acid residues that are affected by 257 
RNA editing (six residues compared to four in Drosophila), there is potential for greater diversity in the 258 
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mosquito Rdl transcriptome. In line with this, we found 22 different editing profiles in 100 cDNA clones 259 
of An. gambiae Rdlbd (Table 1). This considerable increase in Rdl transcript diversity broadens the 260 
functional capabilities of the receptor, as demonstrated by the range of sensitivities to the agonist, GABA 261 
(Table 2), with the fully edited isoform (R119G+I162V+I176V+N183G+I278V+N289D) showing the 262 
greatest change in GABA EC50 compared to the unedited variant. This is in accord with most of the 263 
editing sites occurring within the N-terminal extracellular domain where agonist binding occurs (Fig. 2) 264 
and with findings supporting GABA forming many interactions with different residues (Ashby et al., 265 
2012).  266 
It has become apparent over the past decade that RNA editing may contribute to insecticide 267 
resistance. A reduction in Adar expression in cholinergic neurons and muscle of D. melanogaster reduced 268 
spinosad and imidacloprid sensitivity (Rinkevich and Scott, 2012). Higher levels of RNA A-to-I editing 269 
leading to N133D substitution in the β1 nAChR subunit were found in Nilaparvata lugens resistant to 270 
imidacloprid than in susceptible insects (Yao et al., 2009). In agreement with this, expression in X. laevis 271 
oocytes of nAChRs with the rat 2 subunit mimicking the N133D substitution resulted in reduced 272 
potency of imidacloprid (Yao et al., 2009). Another heterologous expression study found that the R122G 273 
edit in D. melanogaster RDL reduced the receptor’s sensitivity to fipronil (Es-Salah et al., 2008). With 274 
the twelve isoforms studied here, we found that RNA editing of An. gambiae RDL had no effect on the 275 
potency of fipronil (Table 2). This included the fully edited isoform with six amino acid substitutions. 276 
This might be expected considering none of the editing sites are in the pore-lining TM2 region important 277 
for fipronil binding (Buckingham et al., 2005). In contrast, the fully edited isoform of An. gambiae RDL 278 
affected the agonistic, potentiating and antagonistic actions of ivermectin when compared to the unedited 279 
variant (Table 2) (Figs. 6 and 7), highlighting that ivermectin and fipronil have different modes of action 280 
on RDL. The triple action of ivermectin was also observed for M. domestica RDL (Fuse et al., 2016) 281 
where it was suggested that the number of orthosteric binding sites in a homo-pentamer occupied by 282 
GABA determines whether ivermectin is a potentiator or antagonist. Several studies have shown that 283 
residues in the transmembrane domains are important for interactions with ivermectin (Degani-Katzav et 284 
al., 2017; Fuse et al., 2016; Hibbs and Gouaux, 2011; Huang et al., 2017; Nakao et al., 2015; 285 
Wolstenholme, 2012; Zemkova et al., 2014). In line with this, we found that the single edit variant I278V, 286 
which is located in TM1 (Fig. 2), abolished the potentiating action of ivermectin (Fig. 8A). Interestingly, 287 
Lees et al. (Lees et al., 2014) reported that the predominant edit in D. melanogaster RDL, I283V, which 288 
is conserved with I278V in mosquito RDL, had no effect on the antagonistic action of ivermectin when 289 
high concentrations (100 M) of GABA was applied. In contrast, our result suggests that I278V affects 290 
the allosteric action of ivermectin on RDL upon exposure to lower concentrations of GABA. Studies on 291 
the crystallized glutamate-gated chloride of Caenorhabditis elegans, with ivermectin bound or absent, 292 
have shown that parts of the N-terminal extracellular region come into contact with the transmembrane 293 
domain (Althoff et al., 2014; Hibbs and Gouaux, 2011). This enables the coupling of conformational 294 
changes between the two regions of the receptor, which is thought to be involved in carrying out the 295 
allosteric modulatory effects of ivermectin. One of these contacts includes an interaction between the 296 
characteristic cys-loop and the extracellular end of TM3 (Althoff et al., 2014). We found that the N183G 297 
edit isoform in mosquito RDL abolished potentiation by ivermectin (Fig. 8B), reinforcing findings 298 
suggesting that altering the conformation of the cys-loop can affect communication between the agonist 299 
binding regions and the transmembrane domain (Alcaino et al., 2017; Althoff et al., 2014; Lee et al., 300 
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2008; Schofield et al., 2004). Further experiments are required to determine whether any of the remaining 301 
four edited amino acids in An. gambiae RDL also influence ivermectin actions. 302 
Ivermectin has been approved for human use in large scale drug administrations to treat diseases 303 
caused by parasitic nematodes such as river blindness in Africa (resulting from infection by Onchocerca 304 
volvulus) (Tekle et al., 2016) and lymphatic filariasis in over 50 countries (caused by Wuchereria 305 
bancrofti, Brugia malayi and B. timori) (Biritwum et al., 2017). Ivermectin can also treat other parasitic 306 
diseases. For example, a study has shown that ivermectin can reduce prevalence of strongyloidiasis 307 
(caused by Strongyloides stercoralis) in a human population in northwestern Argentina (Echazu et al., 308 
2017) and there is increasing interest in the use of ivermectin to treat scabies (caused by the mite, 309 
Sarcoptes scabiei var hominis) (World Health Organization b). Interestingly, the survival of Anopheles 310 
mosquitoes was reduced when they fed on humans or cattle receiving ivermectin treatment (Chaccour et 311 
al., 2010; Kobylinski et al., 2010; Pooda et al., 2014). This raises the prospect of providing an additional 312 
route to reducing malaria transmission in areas where mass drug administration of ivermectin is used to 313 
treat parasites (Chaccour et al., 2017). Understanding mechanisms that may give rise to ivermectin 314 
insensitivity is crucial in delaying the emergence of resistance, thereby maximizing the potential of this 315 
approach, and studies are ongoing in understanding ivermectin susceptibility in Anopheles (Chaccour et 316 
al., 2017; Seaman et al., 2015). Our findings that RNA editing of An. gambiae RDL affects the potency of 317 
ivermectin may highlight a novel mechanism for increased tolerance to the drug. Whilst ivermectin is 318 
thought to act primarily on glutamate-gated chloride channels (Laing et al., 2017), it may have 319 
toxicological influence by acting on insect GABA receptors, given that activation, potentiation and 320 
antagonism of mosquito RDL can occur at nanomolar concentrations (Table 2, Fig. 7) and that similar 321 
concentrations of ivermectin (up to 40 nanomolar) have been measured in the plasma of patients who 322 
have taken a single oral dose of the drug (Chaccour et al., 2017; Elkassaby, 1991). It would, therefore, be 323 
of interest to determine whether any Anopheles mosquitoes showing differential sensitivity to ivermectin 324 
have altered levels of RNA editing of RDL. 325 
The development of novel compounds, such as isoxazolines (Asahi et al., 2015; Ozoe et al., 326 
2010), meta-diamides (Nakao et al., 2013) and meroterpenoid chrodrimanins (Xu et al., 2015), that can 327 
act on RDL bearing the TM2 resistance mutation (Buckingham et al., 2005) demonstrates that the insect 328 
GABA receptor is still a useful target for the development of novel insecticides. Heterologously 329 
expressed An. gambiae RDL, such as that reported here, may provide a useful tool for evaluating the 330 
effectiveness of compounds on isoforms particular to the mosquito GABA receptor. 331 
In conclusion, the functional diversity of the mosquito GABA receptor, RDL, is broadened 332 
considerably by RNA A-to-I editing, which may serve to fine tune the response of the receptor to its 333 
neurotransmitter, GABA. This highlights that while the genomic DNA of Drosophila, Aedes, Anopheles 334 
and Culex translate to RDL peptide sequences that are almost identical, the genome can be recoded at the 335 
RNA level to give species-specific variants, even amongst different mosquito species. When studying 336 
RDL from a certain species, the whole coding sequence should be analysed to ascertain whether there is 337 
potential RNA editing, as this may have an impact on insecticide potency. 338 
 339 
 340 
 341 
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Table 1 – List of edit profiles present in ac, bc, ad and bd splice variants of 123 cDNA clones of An. 343 
gambiae RDL. The frequency of each profile is included. The edit profiles are arranged in decreasing 344 
frequency found in the bd splice variant. * indicates isoforms used in functional analysis. 345 
Edit profile bd splice 
variant 
ad splice 
variant 
ac splice 
variant 
bc splice 
variant 
R119G+I162V+I176V+N183G+I278V 28* 1 0 0 
I162V+N183G+I278V 11* 3 0 0 
I162V+I176V+N183G+I278V 10* 0 0 0 
N183G+I278V 9 3 1 0 
R119G+I162V+I176V+N183G+I278V+N289D 6* 0 0 0 
N183G 5* 5 0 0 
I162V+N183G 5 0 1 0 
I162V+I176V+N183G+I278V+N289D 4 0 0 0 
I176V+N183G 3 0 0 0 
N183G+I278V+N289D 2 1 0 0 
R119G+I162V+I176V+N183G 2 0 0 0 
I176V+N183G+I278V 2* 2 0 0 
I162V+I176V+N183G 2* 0 0 0 
I176V+N183G+I278V+N289D 2* 0 1 0 
R119G+I162V+N183G+I278V 2 0 0 0 
N183G+N289D 1* 1 0 0 
I162V+N183G+N289D 1 0 0 0 
R119G+I162V+N183G 1 0 0 0 
N183D+I278V 1 0 0 0 
R119G+I162V+N183G+I278V+N289D 1 0 0 0 
R119G+N183G+I278V 1 1 0 0 
R119G+N183G 1* 0 0 0 
I162V+N183G+I278V+N289D 0 2 0 0 
Unedited 0 0 0 1 
Total clones sequenced 100 19 3 1 
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Table 2 – List of GABA EC50s plus Hill coefficient (nH), fipronil and ivermectin IC50s for the unedited, 347 
individual edits, completely edited (R119G+I162V+I176V+N183G+I278V+N289D) and 10 selected An. 348 
gambiae Rdlbd edit profiles found in vivo. Values are the mean ± SEM and representative of 4-11 oocytes 349 
from ≥3 different batches of eggs. *GABA EC50 significantly different to the unedited isoform (P<0.05, 1 350 
way ANOVA with Dunnett’s multiple comparison test). ¥Ivermectin IC50 significant from the unedited 351 
isoform (P<0.05, un-paired t-test).  352 
An. gambiae RDL edit profiles GABA Fipronil Ivermectin 
EC50 
(µM) 
nH IC50 (µM) IC50 (nM) 
Unedited 10 ± 4  0.9 ± 0.1 0.41 ± 0.19 457 ± 118 
Single edit profiles  
R119G 13 ± 5 1.2 ± 0.4 - - 
I162V 5 ± 1 0.7 ± 0.1 - - 
I176V 24 ± 9 1.2 ± 0.1 - - 
N183G 43 ± 7 1.4 ± 0.2 0.38 ± 0.17 - 
N183D 13 ± 4 0.9 ± 0.1 - - 
I278V 25 ± 2 1.5 ± 0.1 - - 
N289D 20 ± 2 1.2 ± 0.2 - - 
Edit combination profiles  
I176V+N183G+I278V+N289D 42 ± 8 1.5 ± 0.2 0.31 ± 0.10 - 
N183G+I278V+N289D 42 ± 10 1.6 ± 0.2 0.28 ± 0.06 - 
N183G+N289D 43 ± 8 1.6 ± 0.2 0.17 ± 0.09 - 
I162V+N183G+I278V 54 ± 16 1.8 ± 0.1 0.43 ± 0.09 - 
R119G+N183G 62 ± 25 1.5 ± 0.2 0.32 ± 0.11 - 
I162V+I176V+N183G+I278V 88 ± 17* 2.2 ± 0.2 0.13 ± 0.04 - 
R119G+I162V+I176V+N183G+I278V 105 ± 13* 2.0 ± 0.2 0.29 ± 0.10 - 
I162V+I176V+N183G 113 ± 25* 1.8 ± 0.1 0.18 ± 0.08 - 
I176V+N183G+I278V 118 ± 55* 1.2 ± 0.2 0.21 ± 0.05 - 
R119G+I162V+I176V+N183G+I278V+N289D  246 ± 41* 1.8 ± 0.18 0.23 ± 0.14 50 ± 24¥ 
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Figure legends 525 
Figure 1. Sequence chromatograms showing RNA A-to-I editing in RDL of Ae aegypti, An. gambiae and 526 
Cx. pipiens. Mixed adenosine/guanosine peaks in the cDNA sequence indicating RNA editing are 527 
highlighted and the resulting amino acid change is shown. The corresponding genomic DNA (gDNA) 528 
sequence of An. gambiae, which lacks the G signal, is also included. 529 
 530 
Figure 2. RNA A-to-I edit sites in RDL are overlapping but not completely conserved between mosquito 531 
species and D. melanogaster. Amino acid sequence alignment of RDLs from D. melanogaster (top line) 532 
with Ae aegypti, An. gambiae and Cx. pipiens (bottom line).  Regions involved in agonist binding (loops 533 
A-F), the cys-loop and the first transmembrane domain (TM1) are highlighted. RNA editing sites 534 
resulting in an amino acid change are identified with an arrow and correspond by symbol to An. gambiae 535 
(filled circle), Ae. aegypti (dotted circle) and Cx. pipiens (open circle).  536 
 537 
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Figure 3. Alternative splicing of exons 3 and 6 in An. gambiae RDL. Equivalent alternative exons of An. 538 
gambiae and D. melanogaster RDLs are aligned. Anopheles residues that differ in spliced exons are 539 
underlined. Anopheles residues, which differ from those of the orthologous Drosophila exon, are 540 
highlighted in bold. 541 
 542 
Figure 4. RNA A-to-I editing in An. gambiae RDL can affect sensitivity to GABA. A) Representative 543 
electrophysiological trace showing responses to GABA (from 1 M – 2 mM) in X. laevis oocytes 544 
expressing the most prevalent Rdlbd edit isoform (R119G+I162V+I176V+N183G+I278V). B) GABA 545 
concentration response curves of unedited Rdlbd and the completely edited isoform 546 
(R119G+I162V+I176V+N183G +I278V+N289D). The two curves have significantly different EC50s 547 
(P<0.05, 1 way ANOVA with Dunnett’s multiple comparison test) (Table 2).  Data are normalised to the 548 
maximal response (1 mM GABA). Data are the mean ± SEM from 5-6 oocytes from 3 different batches 549 
of eggs.  550 
 551 
Figure 5. Effects of RNA editing in An. gambiae RDL on receptor sensitivity to fipronil. A) 552 
Representative electrophysiological trace showing the effects of increasing concentrations of fipronil on 553 
the 1 mM GABA response, in  X. laevis oocytes expressing the most prevalent Rdlbd edit isoform 554 
(R119G+I162V+I176V+N183G+I278V). Concentrations of fipronil (0.0001 M – 10 M) were co-555 
applied with 1 mM GABA following a 3 min pre-incubation with the selected fipronil concentration.  B) 556 
Fipronil inhibition curves for the unedited, completely edited 557 
(R119G+I162V+I176V+N183G+I278V+N289D) and further 10 selected RDL isoforms occuring in vivo. 558 
Each data point was normalized to the response to 1 mM GABA. IC50 values are not significantly 559 
different. Data are the mean ± SEM and representative of 3-4 oocytes from ≥3 different batches of eggs. 560 
Figure 6. Effects of RNA editing in An. gambiae RDL on the antagonistic actions of ivermectin. A)  561 
Representative electrophysiological trace showing the effects of increasing concentrations of ivermectin 562 
on the 1 mM GABA response, in X. laevis oocytes expressing the completely edited 563 
(R119G+I162V+I176V+N183G+I278V+N289D) RDL isoform. Concentrations of ivermectin (0.0001 564 
M – 10 M) were co-applied with 1 mM GABA following a 3 min pre-incubation with the selected 565 
ivermectin concentration. B) Ivermectin inhibition curves for the unedited and completely edited RDL 566 
isoforms. IC50 values are significantly different (P<0.05, un-paired t-test).  Each data point was 567 
normalized to the response to 1 mM GABA. Data are the mean ± SEM and representative of 4-6 oocytes 568 
from ≥3 different batches of eggs. 569 
 570 
Figure 7. Effects of RNA editing in An. gambiae RDL on the activation and potentiation actions of 571 
ivermectin. A) Representative electrophysiological trace showing the agonistic and potentiating effects of 572 
ivermectin on GABA response in X. laevis oocytes expressing the completely edited and unedited 573 
isoforms. B) Curves representing the change in base line (agonist activity) of the completely edited and 574 
unedited RDL isoforms during the preincubation step. * indicates that the amplitude of response to 0.03 575 
M ivermectin in the unedited and completely edited isoforms were significantly different (p-value <0.05, 576 
un-paired t-test). Data are the mean ± SEM and representative of 5-6 oocytes from ≥3 different batches of 577 
19 
 
19 
 
eggs. C) GABA response curves of completely edited and unedited RDL isoforms after preincubation 578 
with ivermectin. Each data point was normalised to the GABA EC20 values obtained before the first 579 
ivermectin preincubation step (value of 1). Data are the mean ± SEM and representative of 5-6 oocytes 580 
from ≥3 different batches of eggs. 581 
 582 
Figure 8. Effect of N183G or I278V editing on the potentiation action of ivermectin. A) GABA response 583 
curves of completely edited, unedited RDL and N183G isoforms after preincubation with ivermectin. B) 584 
GABA response curves of completely edited, unedited RDL and I278V isoforms after preincubation with 585 
ivermectin. Each data point was normalised to the GABA EC20 values obtained before the first ivermectin 586 
preincubation step (value of 1). Data are the mean ± SEM and representative of 3-6 oocytes from ≥3 587 
different batches of eggs. 588 
 589 
